The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"

The current system of health technology development is characterised by multiple misalignments. The "supply" side (innovation policy-makers, entrepreneurs, investors) and the "demand" side (health policy-makers, regulators, health technology assessment, purchasers) operate under...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenhalgh, Trisha, Fahy, Nick, Shaw, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745872/
https://www.ncbi.nlm.nih.gov/pubmed/29325407
http://dx.doi.org/10.15171/ijhpm.2017.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745872/
https://www.ncbi.nlm.nih.gov/pubmed/29325407
http://dx.doi.org/10.15171/ijhpm.2017.65

Ejemplares similares